Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Spyre Therapeutics Will Begin Trading On Nasdaq Under Trading Symbol "SYRE" Effective November 28, 2023; $205M Of Cash, Cash Equivalents, Marketable Securities, And Restricted Cash As Of September 30, 2023, With Expected Runway Into 2026

Author: Benzinga Newsdesk | November 27, 2023 08:43am

Posted In: AGLE